Carnegie Mellon University
In its 13F for Q4 2025 (holdings as of December 31, 2025, filed January 28, 2026), Carnegie Mellon University reported 5 stock positions worth $89.3 million. Its top holding was Duolingo (DUOL) at 57.9% of the portfolio, followed by Invesco QQQ Trust Series 1 (QQQ, 42.0%) and Innsuites Hospitality Trust (IHT, 0.0%). Compared with Q3 2025, it opened 1 new position, sold out of 1, added to 1 and reduced 1. The biggest buy was Invesco QQQ Trust Series 1 (QQQ, shares +0%) and the biggest sale an exit from Predictive Oncology.
- Most Recent 13F
- Q2 2026
- Location
- Pittsburgh, PA
- CIK
- 0001039067
- Portfolio Value
- $89.3M (Q4 2025)
- SEC Filing
- 0000898432-26-000067 ↗ filed Jan 28, 2026
Holdings Value
Holdings 5 stocks · $89.3M
| DUOL Duolingo | 57.94% | 294,814 | $51.7M | No change |
| QQQ Invesco QQQ Trust Series 1 | 42.04% | 61,106 | $37.5M | Add +0.1% |
| IHT Innsuites Hospitality Trust | 0.01% | 10,000 | $13K | No change |
| AGPU Axe Compute Inc. | 0.01% | 691 | $5K | New |
| LONGEVITY HEALTH HLDGS INC | 0.00% | 4,472 | $1K | Reduce -0.2% |
Portfolio Sells Q3 2025 → Q4 2025
| PREDICTIVE ONCOLOGY INC | Sold out | 0.00% | −0.01 |
| LONGEVITY HEALTH HLDGS INC | Reduce -0.2% | 0.00% | −0.00 |
Portfolio Buys Q3 2025 → Q4 2025
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 5 | $78.9M | QQQ, DUOL, IHT, AGPU, LONGEVITY HEALTH HLDGS INC |
| Q1 2026 | 5 | $64.3M | QQQ, DUOL, IHT, LONGEVITY HEALTH HLDGS INC, AGPU |
| Q4 2025 | 5 | $89.3M | DUOL, QQQ, IHT, AGPU, LONGEVITY HEALTH HLDGS INC |
| Q3 2025 | 5 | $131.6M | DUOL, QQQ, IHT, PREDICTIVE ONCOLOGY INC, LONGEVITY HEALTH HLDGS INC |
| Q2 2025 | 5 | $154.6M | DUOL, QQQ, IHT, LONGEVITY HEALTH HLDGS INC, PREDICTIVE ONCOLOGY INC |
| Q1 2025 | 6 | $129.0M | DUOL, QQQ, PDD, IHT, LONGEVITY HEALTH HLDGS INC |
| Q4 2024 | 6 | $136.7M | DUOL, QQQ, PDD, LONGEVITY HEALTH HLDGS INC, IHT |
| Q3 2024 | 4 | $96.9M | DUOL, LONGEVITY HEALTH HLDGS INC, IHT, PREDICTIVE ONCOLOGY INC |
| Q2 2024 | 4 | $73.9M | DUOL, LONGEVITY HEALTH HLDGS INC, IHT, PREDICTIVE ONCOLOGY INC |
| Q1 2024 | 6 | $80.1M | DUOL, VERA, LONGEVITY HEALTH HLDGS INC, PREDICTIVE ONCOLOGY INC, NBSE |